Health related quality of life in men with prostate cancer.

ABSTRACTPurpose: Quality of life is of great concern to patients considering treatment options for prostate cancer. In the absence of clinical trial data clearly demonstrating that a particular treatment is superior to another for localized prostate cancer, in terms of cause specific survival, patients may value quality of life as much as quantity of life. The goal of this review is to familiarize the reader with the methodology of quality of life research and to review the recent literature on quality of life outcomes in prostate cancer.Materials and Methods: A structured MEDLINE review of literature on health related quality of life in prostate cancer for the years 1995 to 2001 was performed, and was augmented with highly relevant articles from additional selected journals.Results: In the case of advanced or metastatic disease, where the goal of treatment is palliation and symptom-free survival, quality of life often becomes the primary desired outcome. In localized disease all treatments affect health ...

[1]  C. McPherson,et al.  Quality of life and treatment outcomes , 1997, Cancer.

[2]  R. Deyo,et al.  Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life , 1989, Medical care.

[3]  J. Richie,et al.  Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Fellin,et al.  Assessment of quality of life after radical radiotherapy for prostate cancer. , 1996, British journal of urology.

[5]  A. Brickman,et al.  Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. , 1995, The Journal of urology.

[6]  M. Barry,et al.  Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. , 1995, Urology.

[7]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[8]  S P McKenna,et al.  Measuring health status: a new tool for clinicians and epidemiologists. , 1985, The Journal of the Royal College of General Practitioners.

[9]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[10]  T M Gill,et al.  A critical appraisal of the quality of quality-of-life measurements. , 1994, JAMA.

[11]  J. Stanford,et al.  Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. , 1999, Journal of the National Cancer Institute.

[12]  G. Kennealey,et al.  Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. , 1995, Urology.

[13]  W. Lee,et al.  A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[14]  J. Richie,et al.  Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. , 1997, Journal of the National Cancer Institute.

[15]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.

[16]  J. Ware,et al.  Health-related quality of life among patients with metastatic prostate cancer. , 1997, Urology.

[17]  S. Fosså,et al.  Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG) , 1997, European journal of cancer.

[18]  M. Litwin,et al.  Quality-of-life outcomes in long-term survivors of advanced prostate cancer. , 1998, American journal of clinical oncology.

[19]  D. Patrick,et al.  Assessing health-related quality of life for clinical decision-making , 1993 .

[20]  R. Heinrich,et al.  Development of a comprehensive quality of life measurement tool: CARES. , 1990, Oncology.

[21]  P. Schellhammer,et al.  Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. , 1999, Urology.

[22]  A. Potosky,et al.  Assessment of patient preferences among men with prostate cancer. , 1998, The Journal of urology.

[23]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Huggins,et al.  STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND , 1941 .

[25]  A. Porter,et al.  Quality of life after permanent prostate implant. , 1997, Seminars in surgical oncology.

[26]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[27]  P. Fransson,et al.  Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma , 1999, Cancer.

[28]  D. Lubeck,et al.  Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. , 1998, The Journal of urology.

[29]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D S Tulsky,et al.  An introduction to test theory. , 1990, Oncology.

[31]  P. Ganz,et al.  CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument , 1991, Cancer.

[32]  H. Herr,et al.  Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. , 2000, The Journal of urology.

[33]  D. Lubeck,et al.  Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. , 1999, Urology.

[34]  S. Malkowicz,et al.  Erectile function and quality of life after interstitial radiation therapy for prostate cancer , 2000, International Journal of Impotence Research.

[35]  P. Johnstone,et al.  Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. , 2000, International journal of radiation oncology, biology, physics.

[36]  D. Lubeck,et al.  Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. , 1999, Urology.

[37]  M. Litwin,et al.  Quality of life outcomes after brachytherapy for early stage prostate cancer. , 2000, The Journal of urology.

[38]  K. Pienta,et al.  Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. , 1997, Urology.

[39]  Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic Trial , 1998 .

[40]  S. Walker,et al.  Quality of Life Assessment: Key Issues in the 1990s , 1993, Springer Netherlands.

[41]  P. Fransson,et al.  Self‐assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age‐matched control population , 1994, Cancer.

[42]  D. Osoba,et al.  Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[44]  P. Ditonno,et al.  Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  D. Smith,et al.  Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer. , 1999, Oncology nursing forum.

[46]  Y. Ohashi,et al.  Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. , 1999, Urology.

[47]  R H Brook,et al.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. , 1998, Medical care.